UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________________________________________________________________________ FORM 10-Q ______________________________________________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 ...

Resmed, Inc. (NYSE:RMD) Q4 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Amy Wakeham - VP, IR & Corporate Communications Michael Farrell - CEO & Director Brett Sandercock - CFO Robert Douglas - President, COO and Interim President, Sleep & Respiratory Care Conference Call Participants Craig Wong-Pan - RBC Capital Markets Sean Laaman - Morgan Stanley Margarate Boeye - William Blair & Company David Bailey - Macquarie Research Michael Matson - Needham & Company Lyanne Harrison - ...

Q4 FY2022 Earnings August 11, 2022 Presentation of financial information & forward-looking statements Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated. This presentation includes financial information prepared in accordance with accounting principles generally accepted in the United States, or GAAP, as well as other financial measures referred to as non-GAAP. The non-GAAP financia ...

SECURITIES AND EXCHANGE COMMISSION UNITED STATES Commission file number: 001-15317 ___________________________________________________________________________________________ ResMed Inc. (Exact name of registrant as specified in its charter) ___________________________________________________________________________________________ Delaware (State or other jurisdiction of incorporation or organization) 98-0152841 (IRS Employer Identification No.) 9001 Spectrum Center Blvd. San Diego, CA 92123 United States ...

Acquisition of MEDIFOX DAN June 14, 2022 Forward-looking statements Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated. This presentation includes financial information prepared in accordance with accounting principles generally accepted in the United States, or GAAP, as well as other financial measures referred to as non-GAAP. The non-GAAP financial measures in this presentation, w ...

Q3 FY2022 Earnings April 28, 2022 Presentation of financial information & forward-looking statements Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated. This presentation includes financial information prepared in accordance with accounting principles generally accepted in the United States, or GAAP, as well as other financial measures referred to as non-GAAP. The non-GAAP financial ...

ResMed Inc. (NYSE:RMD) Q3 2022 Earnings Conference Call April 28, 2022 4:30 PM ET Company Participants Amy Wakeham - VP, IR & Corporate Communications Mick Farrell - CEO Brett Sandercock - CFO Rob Douglas - President and COO Jim Hollingshead - President, Sleep & Respiratory Care business David Pendarvis - Chief Administrative Officer and Global General Counsel Conference Call Participants David Low - JPMorgan Gretel Janu - Credit Suisse Lyanne Harrison - Bank of America Saul Hadassin - Barrenjoey Dan Hurren ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________________________________________________________________________ FORM 10-Q ______________________________________________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For ...

ResMed Inc. (NYSE:RMD) Q2 2022 Earnings Conference Call January 27, 2021 4:30 PM ET Company Participants Amy Wakeham - VP, IR & Corporate Communications Mick Farrell - CEO Brett Sandercock - CFO Rob Douglas - President and COO Jim Hollingshead - President, Sleep & Respiratory Care business David Pendarvis - Chief Administrative Officer and Global General Counsel Conference Call Participants Chris Cooper - Goldman Sachs Dan Hurren - MST Marquee Sean Laaman - Morgan Stanley Matthew Mishan - KeyBanc Craig Wong ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Delaware (State or other jurisdiction of incorporation or organization) 98-0152841 (I.R.S. Employer Identification No.) WASHINGTON, DC 20549 ______________________________________________________________________________________________ FORM 10-Q ______________________________________________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly per ...